“…Through the GPRs on the surface of intestinal endocrine cells, SCFAs promote the secretion of intestinal hormones, such as glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY; Zhang et al, 2019a;Ren et al, 2020;Wang et al, 2020;Nishida et al, 2021). In particular, GLP-1 enhances glucose tolerance and regulate metabolism (Suzuki and Aoe, 2021), whereas PYY increases satiety, reduces food intake, regulates intestinal movement and slows down gastric emptying to improve body metabolism (Freire and Alvarez-Leite, 2020;Nishida et al, 2021). GPRs affect the influence of gut microbiota on the body's energy, i.e.…”